(Q36930712)

English

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases

scientific article published on 30 November 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

connective tissue

1 reference

based on heuristic

inferred from title

arterial hypertension

1 reference

based on heuristic

inferred from title

Gabriela Riemekasten

7

object named as

G Riemekasten

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1 reference

ORCID Public Data File 2021

author name string

C P Denton

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

J E Pope

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

H-H Peter

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A Gabrielli

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A Boonstra

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

F H J van den Hoogen

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

S De Vita

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A Morganti

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

M Dölberg

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

O Berkani

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

L Guillevin

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

TRacleer Use in PAH associated with Scleroderma and Connective Tissue Diseases (TRUST) Investigators

13

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

language of work or name

0 references

publication date

30 November 2007

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

67

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

1222-1228

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Using a self-reported functional score to assess disease progression in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

New therapeutic strategies in the management of systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Connective tissue associated pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Pulmonary arterial hypertension associated to connective tissue diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Diagnosis and differential assessment of pulmonary arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Joint damage and disability in rheumatoid arthritis: an updated systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Novel therapeutic agents for systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Recommendations on the management of pulmonary hypertension in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Novel therapeutic strategies in scleroderma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

Lung disease in systemic sclerosis (scleroderma).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

29 September 2017

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

27 June 2018

Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Inverse correlation of each functional status scale of the SF-36 with degree of disease activity in systemic lupus erythematosus (m-SLAM)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Psychiatric symptoms associated with scleroderma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 September 2018

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564804

4 December 2018

Respiratory complications in mixed connective tissue disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in systemic sclerosis as measured by the short form 36: Relationship with clinical and biologic markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary hypertension in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physical disability and psychosocial dysfunction in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma and related disorders: therapeutic aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostanoid therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary and secondary pulmonary hypertension in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary hypertension in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary hypertension in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18055477

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2007.079921

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36930712&oldid=2150393924"